Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. - Archive ouverte HAL Access content directly
Journal Articles International Journal of Radiation Oncology, Biology, Physics Year : 2006

Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.

(1, 2) , (1, 2) , (1, 2) , (1, 2) , (3) , (1, 4) , (1, 5) , (1, 2, 4) , (1, 2)
1
2
3
4
5

Abstract

PURPOSE: Heavy-atom-enhanced synchrotron stereotactic radiotherapy (SSR) is a treatment that involves selective accumulation of high-Z elements in tumors followed by stereotactic irradiation with X-rays from a synchrotron source. The purpose of this study was to determine whether the efficacy of iodine-enhanced SSR could be further improved in the F98 rodent glioma model, by using a concomitant injection of an iodinated contrast agent and a transient blood-brain barrier opener (mannitol) during irradiation. METHODS AND MATERIALS: Fourteen days after intracerebral inoculations of F98 cells, the rats were irradiated with 50-keV X-rays while receiving an infusion of hyperosmotic mannitol with iodine, either intravenously or via the carotid (9 to 15 rats per group, 117 rats total). RESULTS: For doses
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-00388754 , version 1 (15-10-2009)

Identifiers

Cite

Jean-François Adam, Aurélie Joubert, Marie-Claude Biston, Anne-Marie Charvet, Michel Peoc'H, et al.. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.. International Journal of Radiation Oncology, Biology, Physics, 2006, 64 (2), pp.603-11. ⟨10.1016/j.ijrobp.2005.09.004⟩. ⟨inserm-00388754⟩

Collections

INSERM UGA U836
117 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More